Standard BioTools Inc.LABNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank79
3Y CAGR-3.9%
5Y CAGR+0.2%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-3.9%/yr
vs +8.7%/yr prior
5Y CAGR
+0.2%/yr
Recent deceleration
Acceleration
-12.6pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$135.85M-47.6%
2024$259.50M+104.2%
2023$127.05M-17.1%
2022$153.26M+12.0%
2021$136.83M+1.8%
2020$134.36M+15.7%
2019$116.12M+5.7%
2018$109.81M-0.5%
2017$110.34M-16.2%
2016$131.63M-